Brief: MediciNova Receives Notice Of Allowance For New Patent Covering MN-166 For Prevention Of Metastasis Of Various Solid Cancer
05/06/2024 13:09
June 5 (Reuters) - MediciNova Inc MNOV.O :
* MEDICINOVA RECEIVES NOTICE OF ALLOWANCE FOR NEW PATENT
COVERING
MN-166 (IBUDILAST) FOR THE PREVENTION OF METASTASIS OF VARIOUS
SOLID CANCER
Source text for Eikon: ID:nGNX7ZXkPv
Further company coverage: MNOV.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Medicinova
See all newsBrief: 3D Investment Partners Cuts Stake In Medicinova To 9.88% From 11.22%, Filing Shows
US STOCKS ON THE MOVE-Mirum Pharmaceuticals, Meta, Boeing
U.S. STOCKS ON THE MOVE-Royal Caribbean Cruises, SpaceX
MediciNova falls as fatty liver drug misses significance on blood-fat reduction
US STOCKS ON THE MOVE-WhiteHawk, Nvidia, Snowflake